Zeus Orthocare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-07-2024
- Paid Up Capital ₹ 1.00 M
as on 31-07-2024
- Company Age 10 Year, 26 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.70 M
as on 31-07-2024
- Revenue 24.86%
(FY 2023)
- Profit -16.74%
(FY 2023)
- Ebitda -13.18%
(FY 2023)
- Net Worth 38.71%
(FY 2023)
- Total Assets 19.33%
(FY 2023)
About Zeus Orthocare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹3.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sahil Patel and Sagar Patel serve as directors at the Company.
- CIN/LLPIN
U85191GJ2014PTC081651
- Company No.
081651
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Kalol, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zeus Orthocare Private Limited offer?
Zeus Orthocare Private Limited offers a wide range of products and services, including Orthopedic Trauma Implants, LCP Plates, Orthopedic Implants Plates, Orthopedic Equipment & Supplies, Locking Plates, Bone Plates, Orthopedic Implants.
Who are the key members and board of directors at Zeus Orthocare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Patel  | Director | 01-Aug-2021 | Current |
| Sahil Patel | Director | 24-Dec-2014 | Current |
Financial Performance of Zeus Orthocare.
Zeus Orthocare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.86% increase. The company also saw a substantial fall in profitability, with a 16.74% decrease in profit. The company's net worth Soared by an impressive increase of 38.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zeus Orthocare?
In 2023, Zeus Orthocare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Central Bank Of India Creation Date: 22 May 2015 | ₹3.70 M | Satisfied |
How Many Employees Work at Zeus Orthocare?
Zeus Orthocare has a workforce of 28 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeus Orthocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeus Orthocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
